RVMD logo

RVMD
Revolution Medicines Inc

2,196
Mkt Cap
$31.88B
Volume
168,600.00
52W High
$155.70
52W Low
$34.00
PE Ratio
-21.20
RVMD Fundamentals
Price
$148.55
Prev Close
$149.94
Open
$150.00
50D MA
$118.62
Beta
1.12
Avg. Volume
4.26M
EPS (Annual)
-$5.95
P/B
20.01
Rev/Employee
$0.00
$13,545.26
Loading...
Loading...
News
all
press releases
$100 Invested In Revolution Medicines 5 Years Ago Would Be Worth This Much Today
read more...
Benzinga·3d ago
News Placeholder
More News
News Placeholder
Revolution Medicines (RVMD) Receives FDA's Safe to Proceed Letter for Daraxonrasib
Revolution Medicines (RVMD) Receives FDA's Safe to Proceed Letter for Daraxonrasib...
Yahoo! Finance: News·4d ago
News Placeholder
RVMD Reports Wider-Than-Expected Loss in Q1, Raises '26 Expense View
Revolution Medicines posts a wider Q1 loss and raises its 2026 expense outlook as R&D and commercial prep costs climb.
Zacks·7d ago
News Placeholder
Revolution Medicines (NASDAQ:RVMD) Releases Quarterly Earnings Results, Misses Expectations By $0.46 EPS
Revolution Medicines (NASDAQ:RVMD - Get Free Report) issued its earnings results on Wednesday. The company reported ($2.29) earnings per share (EPS) for the quarter, missing the consensus estimate of...
MarketBeat·8d ago
News Placeholder
Revolution Medicines, Inc. $RVMD Shares Sold by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D reduced its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 14.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,085 shares of the...
MarketBeat·9d ago
News Placeholder
Are These 5 Biotech Stocks Set to Beat Q1 Earnings Estimates?
ANI Pharmaceuticals, Novavax and three other biotechs show strong Earnings ESP signals, hinting at potential Q1 earnings beat as sector results roll in.
Zacks·10d ago
News Placeholder
Jennison Associates LLC Takes $24.31 Million Position in Revolution Medicines, Inc. $RVMD
Jennison Associates LLC bought a new stake in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 305,260 shares of the company's stock, valued at approximately $24...
MarketBeat·12d ago
News Placeholder
Revolution Medicines, Inc. $RVMD Shares Bought by Vanguard Group Inc.
Vanguard Group Inc. raised its position in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 16,719,886 shares of the company's stock...
MarketBeat·13d ago
News Placeholder
Pictet Asset Management Holding SA Reduces Stake in Revolution Medicines, Inc. $RVMD
Pictet Asset Management Holding SA lowered its holdings in Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 13.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 1,137,121 shares of the company's stock after selling 174,620 shares during...
MarketBeat·15d ago
News Placeholder
Revolution Medicines, Inc. $RVMD Shares Bought by UBS Group AG
UBS Group AG raised its holdings in shares of Revolution Medicines, Inc. (NASDAQ:RVMD - Free Report) by 183.6% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,087,937 shares of the company's stock...
MarketBeat·15d ago
<
1
2
...
>

Latest RVMD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.